Momenta Pharmaceuticals Inc. (MNTA) Financials Nov 14,

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
Momenta Pharmaceuticals Inc. (MNTA) Financials Nov 14, 2014, 4:28 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Momenta Pharmaceuticals Inc.


Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 20.25M 116.77M 283.07M 63.92M 35.47M
Cost of Goods Sold (COGS) incl. D&A 4.8M 4.7M 5.52M - -
COGS excluding D&A 0 0 0 - -
Depreciation & Amortization Expense 4.8M 4.7M 5.52M 7.48M 8.17M
Depreciation 4.47M 4.4M 4.1M 6.42M 7.11M
Amortization of Intangibles 326,000 299,000 1.42M 1.06M 1.06M
Gross Income 15.45M 112.07M 277.55M - -
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 79.62M 75.61M 93.35M 116.55M 136.89M
Research & Development 60.61M 51.71M 64.66M 80.35M 104M
Other SG&A 19M 23.9M 28.7M 36.2M 32.89M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 4.5M - -
EBIT after Unusual Expense 0 0 (4.5M) - -
Non Operating Income/Expense (104,000) 978,000 0 220,000 233,000
Non-Operating Interest Income 825,000 176,000 746,000 1.24M 950,000
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 570,000 329,000 91,000 0 0
Gross Interest Expense 570,000 329,000 91,000 0 0
Interest Capitalized 0 0 0 0 0
Pretax Income (64.01M) 37.29M 180.36M (58.65M) (108.41M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (64.01M) 37.29M 180.36M (58.65M) (108.41M)
Minority Interest Expense 0 0 0 0 0
Net Income (64.01M) 37.29M 180.36M (58.65M) (108.41M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg - - - 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (64.01M) 37.29M 180.36M (58.65M) (108.41M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (64.01M) 37.29M 180.36M (58.65M) (108.41M)
EPS (Basic) (1.60) 0.84 3.62 (1.16) (2.13)
Basic Shares Outstanding 40.06M 44.63M 49.85M 50.41M 50.91M
EPS (Diluted) (1.60) 0.81 3.55 (1.16) (2.13)
Diluted Shares Outstanding 40.06M 45.94M 50.82M 50.41M 50.91M
EBITDA (59.37M) 41.17M 189.72M (52.63M) (101.42M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Miracle League Marks Two Decades with Big Fundraising Win

Updated Category News Views 58

A Double Decade Celebration of Dream and Dedication The Miracle League of the Triangle sure knows how to throw a party—for them, it's not just a gala; it's a testament to two decades of turning dreams into reality. On October 13th, over 300 guests gathered at the Angus Barn Pavilion in Cary, NC, proving that passion for inclusive baseball is just as alive as it was 20...

Continue Reading
Extra Mile Day: 18 Years of Honoring Unsung Heroes

Updated Category News Views 49

Pedaling for Purpose: A Journey That Sparked a Movement What started as a lone journey across America's roads has turned into a celebrated movement to honor those who often go unnoticed. Back in 2009, Shawn Anderson embarked on an unusual journey. Armed only with a bicycle and determination, he pedaled from San Francisco to Boston—over 4,000 miles in just 90 days. It...

Continue Reading
Fidelis Care Opens $120K Workforce Grants for Aid

Updated Category News Views 112

Fidelis Care Steps Up Workforce Engagement Fidelis Care's latest move introduces a fresh shot at tackling two birds with one stone—economic and health stability for Medicaid members. The Workforce Pathways to Health and Economic Mobility grants present up to $120,000 in support for New Yorkers, an attempt aimed squarely at reducing the vicious cycle that traps many in...

Continue Reading
Nelson Peltz Doubles Down: Burgers or Pucks?

Updated Category News Views 53

Mixing Hockey and Hamburgers: The Peltz Way You'd think a guy like Nelson Peltz wouldn't be juggling hockey sticks and hamburgers at the same time, but here we are. The man, a mogul of sorts with Trian Fund Management, is hopping onto a board seat with a New York hockey company and, oh, by the way, throwing a non-binding $7.35-a-share cash proposal to snatch up Wendy's, a...

Continue Reading
Jamaica's Tourism Rebounds Post-Hurricane Challenges

Updated Category News Views 128

Weathering the Storm: A New Chapter for Jamaica It's been nearly a year since Hurricane Melissa hit, and Jamaica is proving that it won't be pushed around by nature's whims. The island's tourism industry, once battered, is now showing remarkable resilience. With hotels and villas reopening and shaking off the dust, it's safe to say Jamaica is back on its feet, and it's...

Continue Reading
Virginia Cancer Specialists: Leaders in Trusted Cancer Care

Updated Category News Views 42

Decades of Trust in Cancer Care Virginia Cancer Specialists isn't just another name in the sea of healthcare providers. That pride they're feeling? Well, they've got every right to it. Just slapped their physicians' names all over the latest Washingtonian's Top Doctors list for 2026. And this isn’t some under-the-table handshake deal. No, this list is shaped by peer...

Continue Reading
Genefluence Launches Rapid UTI PCR Test at Chelsea Hospital

Updated Category News Views 44

There's a fresh breeze blowing through the dusty corridors of healthcare, shaking things up for the better. You see, Genefluence, the brainchild of Professor Chris Toumazou, isn't just throwing a bunch of tech jargon around—it's setting the stage for a much-needed shake-up in how we handle urinary tract infections (UTIs) and, believe me, it couldn’t have come sooner....

Continue Reading
Unicycive Faces Legal Heat: Shareholder Lawsuit Looms

Updated Category News Views 58

The Unicycive Landslide: What Went Down? Investors, buckle up. Unicycive Therapeutics Inc. (NASDAQ: UNCY) finds itself deep in the muck of a securities class action. Chief honchos, CEO Shalabh Gupta and CFO John Townsend, are taking the heat for allegedly controlling company disclosures that led shareholders to believe in non-existent progress with their third-party...

Continue Reading
Infoya Surges with 665% Growth, Wins Fast 50 Spot

Updated Category News Views 102

From Humble Beginnings to High Achiever Alright, let's touch base on Canada's tech landscape for a moment. Infoya's leap into Deloitte's 2026 Technology Fast 50 isn't just a pat on the back—it's a flashing neon sign of what raw ambition mixed with a pinch of AI can cook up for you. They've banked a whopping 665% revenue growth from 2022 to 2025. Not bad for a company...

Continue Reading
Heritage Wines Meet Non-Alcoholic Trend: New Deal

Updated Category News Views 49

Wine Industry Shifts Gears Well, here's a twist that might just shake up the wine racks. C. Mondavi & Family, from the historic Charles Krug estate, is aligning with Missing Thorn—a name gaining traction in the non-alcoholic wine scene. It’s a move that not only raises eyebrows but could also expand your wine-tasting options come your next sober night out. So what...

Continue Reading

Top 5 Most Recently Viewed Articles

Infortar's Share Buyback Strategy and Recent Transactions

Updated Category News Views 176

Infortar's Share Buyback Strategy Infortar is actively engaging in a share buyback program on the Nasdaq Tallinn Stock Exchange. This initiative reflects a strategic approach towards securing and stabilizing their market presence. During a recent period, Infortar made notable acquisitions of its own shares, an activity that signals confidence in its long-term value....

Continue Reading
Cisco's Stock Surges to New Heights Amid Innovative Growth

Updated Category News Views 349

Cisco Sets New Milestone with 52-Week High Cisco Systems Inc (NASDAQ: CSCO) has achieved a remarkable milestone as its shares soared to a 52-week high of $60.23. This surge reflects the company's impressive growth trajectory and consistent performance over the past year. With a current market capitalization of $239.6 billion, analysts suggest that the stock may be...

Continue Reading
Insight into Life Science REIT Plc's Recent Disclosure Process

Updated Category News Views 124

Understanding the Disclosure Process for Life Science REIT Plc The disclosure of relevant securities for companies listed on the stock exchange is crucial for maintaining transparency and regulatory compliance. One important example is the recent public opening position disclosure by Life Science REIT Plc, a notable name in the real estate investment trust sector. This...

Continue Reading
November Energy Stocks Worth Watching: High Potential Picks

Updated Category News Views 874

Opportunities in Oversold Energy Stocks In the energy sector, there is often potential for long-term gains hidden within oversold stocks. When a stock exhibits an oversold condition, it's usually an indicator that investor sentiment has driven the price down more than justified by the company's fundamentals. This presents a buy opportunity for savvy investors....

Continue Reading
Terranet's Technology Development Progress Report

Updated Category News Views 104

Terranet's Technology Development Progress Report Recently, Terranet has shared updates with stakeholders regarding its advancements in technology during the second quarter. The company has begun the initial integration of its system into a vehicle, which will lead to an expanded testing phase that will be reported back to the market. The analyses confirm that the ongoing...

Continue Reading